Rare diseases
Investigational molecules
Locations
10 Stratton Street, W1J 8LG, United Kingdom
Clinical research in AR+/HER2-/ER+ breast cancer focuses on patients with locally advanced or metastatic disease, with interest in treatment settings where endocrine and receptor-directed pathways are relevant.
The sponsor’s work in this area centres on therapeutic options for difficult-to-treat breast malignancies.
Ellipses Pharma Limited runs clinical trials in conditions such as Neoplasm malignant, Non-small cell lung cancer metastatic, Medullary thyroid cancer, Breast cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
Spain
The NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
